Rutgers Robert Wood Johnson Medical School is a medical school of Rutgers University. It is one of the two graduate medical schools of Rutgers Biomedical and Health Sciences, together with New Jersey ...

During the past decade, Rutgers Robert Wood Johnson Medical School conducted 79 clinical trials. In the 10-year time frame, 79 clinical trials started and 59 clinical trials were completed, i.e. on average, 74.7% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 30 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rutgers Robert Wood Johnson Medical School" #1 sponsor was "Rutgers, The State University of New Jersey" with 31 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 14 trials sponsored, "Edwards Lifesciences" with 7 trials sponsored, "Pfizer" with 6 trials sponsored and "Target PharmaSolutions, Inc." with 6 trials sponsored. Other sponsors include 113 different institutions and companies that sponsored additional 90 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rutgers Robert Wood Johnson Medical School" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 7 trials as a collaborator, "Cystic Fibrosis Foundation" with 6 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 6 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 5 trials as a collaborator. Other collaborators include 144 different institutions and companies that were collaborators in the rest 128 trials.

According to Clinical.Site data, the most researched conditions in "Rutgers Robert Wood Johnson Medical School" are "HIV Infections" (16 trials), "Cystic Fibrosis" (12 trials), "Parkinson's Disease" (7 trials), "Hypertension" (5 trials) and "Depression" (4 trials). Many other conditions were trialed in "Rutgers Robert Wood Johnson Medical School" in a lesser frequency.

Most popular intervention types in "Rutgers Robert Wood Johnson Medical School" are "Drug" (100 trials), "Other" (25 trials), "Behavioral" (22 trials), "Device" (19 trials) and "Biological" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Nevirapine" (6 trials), "Zidovudine" (6 trials), "Didanosine" (5 trials) and "IVA" (4 trials). Other intervention names were less common.

The vast majority of trials in "Rutgers Robert Wood Johnson Medical School" are 161 trials for "All" genders, 18 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Rutgers Robert Wood Johnson Medical School". undefined are not yet recruiting, 22 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 123 completed trials in Rutgers Robert Wood Johnson Medical School, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Rutgers Robert Wood Johnson Medical School, 17 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 41 trials that are defined as “Not Applicable".